Fulcrum Therapeutics Expects $240 Million Cash Position as of December 31, 2024
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) recently provided an update on its financial situation through an updated corporate presentation published on its website on January 13, 2025. While the comprehensive financial results for the fourth quarter and fiscal year ending December 31, 2024, are yet to be finalized, the company anticipates reporting approximately $240 million in […]
More Stories
Thrivent Financial for Lutherans Sells 355 Shares of Target Co. (NYSE:TGT)
Thrivent Financial for Lutherans cut its holdings in shares of Target Co. (NYSE:TGT – Free Report) by 1.3% during the...
Integras Partners LLC Buys New Shares in Alphabet Inc. (NASDAQ:GOOGL)
Integras Partners LLC purchased a new stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) in the 4th quarter, according to...
JPL Wealth Management LLC Takes $7.93 Million Position in Alphabet Inc. (NASDAQ:GOOGL)
JPL Wealth Management LLC acquired a new position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) in the fourth quarter, HoldingsChannel...
Thrivent Financial for Lutherans Has $3.71 Million Stake in CME Group Inc. (NASDAQ:CME)
Thrivent Financial for Lutherans lessened its position in CME Group Inc. (NASDAQ:CME – Free Report) by 5.2% in the fourth...
Maryland State Retirement & Pension System Has $36.38 Million Position in JPMorgan Chase & Co. (NYSE:JPM)
Maryland State Retirement & Pension System lowered its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 7.9% in...
Xponance Inc. Purchases 3,608 Shares of JPMorgan Chase & Co. (NYSE:JPM)
Xponance Inc. increased its position in JPMorgan Chase & Co. (NYSE:JPM) by 0.9% in the 4th quarter, HoldingsChannel reports. The...